Teva Pharmaceutical Industries Limited
TEVA
$15.71
$0.020.13%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -158.00M | -1.29B | -1.64B | -959.00M | -453.00M |
| Total Depreciation and Amortization | 1.02B | 1.03B | 1.06B | 1.06B | 1.08B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.49B | 2.16B | 2.26B | 1.66B | 983.00M |
| Change in Net Operating Assets | -964.00M | -638.00M | -435.00M | 102.00M | -442.00M |
| Cash from Operations | 1.39B | 1.27B | 1.25B | 1.86B | 1.17B |
| Capital Expenditure | -500.00M | -501.00M | -498.00M | -488.00M | -489.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 0.00 | 0.00 | -15.00M | -15.00M | -15.00M |
| Divestitures | 68.00M | 60.00M | 43.00M | 39.00M | 11.00M |
| Other Investing Activities | 1.34B | 1.29B | 1.26B | 1.36B | 1.30B |
| Cash from Investing | 907.00M | 849.00M | 792.00M | 891.00M | 807.00M |
| Total Debt Issued | 2.31B | -- | -- | 0.00 | 700.00M |
| Total Debt Repaid | -4.35B | -3.01B | -1.64B | -1.46B | -2.66B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -364.00M | -375.00M | -150.00M | -237.00M | -313.00M |
| Cash from Financing | -2.41B | -3.38B | -1.79B | -1.69B | -2.27B |
| Foreign Exchange rate Adjustments | 19.00M | -25.00M | -174.00M | 15.00M | -118.00M |
| Miscellaneous Cash Flow Adjustments | -1.00M | 0.00 | -1.00M | 0.00 | 0.00 |
| Net Change in Cash | -97.00M | -1.29B | 73.00M | 1.07B | -412.00M |